News
Hosted on MSN25d
BioVersys secures patent claims in China for BV100Biopharmaceutical company BioVersys has announced the grant of key patent claims in China for BV100, the intravenous formulation of rifabutin. The technology is being developed to combat resistant ...
Find all the commercial and brand names of generic drug called Rifabutin. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...
BioVersys highlighted the urgent need for safe treatments for CRAB infections, which can have death rates in hospitals as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results